Abstract
This review describes the secondary cancer after radiotherapy. Secondary cancer is a great concern for cancer survivors, especially for childhood cancer survivors not only because of their intrinsic high susceptibility to radiation but also because of successful achievement of longer survival. Recent advance of molecular biology reveals unique genomic changes, which distinguish radiation-induced tumors from spontaneous or chemically induced tumors.
MeSH terms
-
Animals
-
Antineoplastic Agents, Alkylating / adverse effects
-
Child
-
Disease Models, Animal
-
Dose-Response Relationship, Radiation
-
Female
-
Genome-Wide Association Study
-
Humans
-
Ikaros Transcription Factor / genetics
-
Loss of Heterozygosity
-
Lymphoma, T-Cell / etiology
-
Male
-
Mice
-
Mutation
-
Neoplasms, Radiation-Induced / epidemiology
-
Neoplasms, Radiation-Induced / etiology*
-
Neoplasms, Second Primary / epidemiology
-
Neoplasms, Second Primary / etiology*
-
Radiotherapy / adverse effects*
-
Radiotherapy / methods
-
Radiotherapy Dosage
-
Risk
-
Smoking / adverse effects
Substances
-
Antineoplastic Agents, Alkylating
-
Zfpn1a1 protein, mouse
-
Ikaros Transcription Factor